Evidence map›Paper›PMID 35734555›Full record

ArticleTranslational animal science2022

Effects of standardized ileal digestible lysine on growth performance and economic return in duroc-sired finishing pigs.

Larissa L Becker, Emily E Scholtz, Joel M DeRouchey, Mike D Tokach, Jason C Woodworth, Robert D Goodband, Jon A De Jong, Fangzhou Wu, Kiah M Berg, Joe P Ward and 2 more

Open access · goldAbstract read
In one paragraph

Article in Translational animal science, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Larissa L BeckerDepartment of Animal Sciences and Industry, College of Agriculture, Kansas State University, KS, USA.
Emily E ScholtzPipestone Nutrition, Pipestone, MN, USA.
Joel M DeRoucheyDepartment of Animal Sciences and Industry, College of Agriculture, Kansas State University, KS, USA.
Mike D TokachDepartment of Animal Sciences and Industry, College of Agriculture, Kansas State University, KS, USA.
Jason C WoodworthDepartment of Animal Sciences and Industry, College of Agriculture, Kansas State University, KS, USA.ORCID https://orcid.org/0000-0001-7268-4278
Robert D GoodbandDepartment of Animal Sciences and Industry, College of Agriculture, Kansas State University, KS, USA.
Jon A De JongPipestone Nutrition, Pipestone, MN, USA.
Fangzhou WuPipestone Nutrition, Pipestone, MN, USA.
Kiah M BergPipestone Nutrition, Pipestone, MN, USA.
Joe P WardPipestone Nutrition, Pipestone, MN, USA.
Casey R NeillPipestone Nutrition, Pipestone, MN, USA.
Jordan T GebhardtDepartment of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, KS 66506-0201, USA.ORCID https://orcid.org/0000-0002-6144-6714
Kansas State University · USPipestone (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In the United States, emphasis has shifted toward improved pork quality and has resulted in greater use of Duroc-based terminal sires. Duroc sires have differences in ADG, ADFI, G:F, and carcass leanness compared to other sires. Therefore, our objective was to determine the standardized ileal digestible (SID) Lys estimates for Duroc-based sired finishing pigs. In Exp. 1, 2,124 pigs (DNA 600 ×PIC 1050, initially 48.9 kg) were used with 24-27 pigs per pen and 16 pens per treatment. Corn-soybean meal-based diets were fed in three phases (49-59, 59-71, and 71-81 kg). Pens were randomly allotted to 1 of 5 treatments based as a percentage of PIC (2016) SID Lys estimates for gilts (85%, 95%, 103%, 110%, and 120%). Phase 1 diets were formulated to 0.90%, 1.01%, 1.09%, 1.17%, and 1.27%, phase 2 to 0.79%, 0.87%, 0.94%, 1.03%, and 1.10%, and phase 3 to 0.71%, 0.78%, 0.85%, 0.92%, and 0.99% SID Lys. Increasing SID Lys increased (linear,

Indexed as

carcass traitseconomicsfinishing piggrowthlysine requirement

Identifiers

PMID35734555
PMCPMC9206717
OpenAlexW4281251118

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.